Our study further showed that serum Trim72 were significantly elevated in candidemia patients compared to healthy controls on day of first blood culture positivity for C. albicans, and that survivors of candidemia patients had significantly higher serum Trim72 levels than non-survivors. This evidence concerns the gene TRIM72 and Candidemia.